Ceruminous Adenocarcinoma, from the CureRays guide library.

Ceruminous adenocarcinoma is a rare cancer of the wax-producing glands lining the outer ear canal; treatment is complete surgical removal, often followed by radiation, with long-term follow-up because it can recur locally.

What it is.

Ceruminous adenocarcinoma is a rare cancer that arises from the ceruminous glands — the modified sweat glands in the skin of the outer ear canal that produce earwax (cerumen). Because these glands exist only in the outer third of the ear canal, that is where the tumor starts. It usually appears in middle-aged or older adults as a slowly enlarging lump or fullness in the ear canal, sometimes with hearing loss, discharge, bleeding, or pain, and it can be mistaken at first for wax buildup, an infection, or a benign growth. There are several related ceruminous gland cancers, including ceruminous adenoid cystic carcinoma (which, like its relatives elsewhere, tends to invade along nerves) and ceruminous mucoepidermoid carcinoma. These tumors grow in a confined, anatomically complex area near the middle ear, facial nerve, and skull base, which makes complete removal challenging. The mainstay of treatment is wide surgical removal with clear margins. Radiation is frequently added after surgery — particularly for higher-grade tumors, close or positive margins, nerve invasion, or the adenoid cystic type — to improve local control. Because these cancers can recur locally even years later, careful long-term follow-up is important; distant spread is uncommon.

How radiation treats it.

Radiation damages the DNA inside cancer cells so they can no longer divide and survive, while healthy cells are better at repairing themselves. In ceruminous adenocarcinoma, radiation is most often given after surgery to lower the chance the cancer returns in the ear canal — especially when the tumor is higher-grade, the margins are close, or the cancer (particularly the adenoid cystic type) has invaded along nerves, in which case the radiation field is shaped to follow those nerve pathways. Because the ear canal sits near the brain, inner ear, and facial nerve, the dose is carefully shaped, and for tumors at the skull base specialized proton beams may be used to spare those structures. Radiation is given as short, painless daily sessions and leaves no radioactivity in your body, so you remain safe to be around family and children.

The ways we can treat it.

Surgery. Wide local excision — sometimes including removal of part of the ear canal and surrounding bone — removes the tumor with a cuff of normal tissue, the decisive treatment.

External-beam radiation. Focused radiation after surgery treats the tumor bed and, for nerve-invading types, the nerve pathways, improving local control while shaping the dose around the ear and brain.

Particle radiation (selected). For tumors near the skull base or those invading along nerves, proton-beam radiation can deliver a high dose while sparing the brain, inner ear, and other nearby structures.

Questions we hear often.

Is this just a wax problem or an infection? No. Ceruminous adenocarcinoma starts in the wax-producing glands of the outer ear canal and can look at first like wax buildup, an infection, or a benign lump. A persistent lump, bleeding, discharge, or pain in the ear canal should be evaluated, and a biopsy confirms whether it is cancer.

Will I need radiation after surgery? Often, but not always. Radiation is added when the tumor is higher-grade, the margins are close or involved, or the cancer has invaded along nerves — features that raise the chance of it returning. For a small, completely removed low-grade tumor, surgery alone may be enough.

Will I lose my hearing? It depends on how far the tumor extends and how much of the ear canal must be removed. Surgeons aim to remove the cancer completely while preserving as much hearing and structure as possible, and your team can explain what to expect for your specific tumor.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.